PRTK Annual Debt To Equity
-1.50
+0.49+24.62%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual debt to equity ratio is -1.50, with the most recent change of +0.49 (+24.62%) on December 31, 2022. During the last 3 years, it has risen by +5.08 (+77.20%).PRTK Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Debt To Equity
-1.28
+0.08+5.88%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly debt to equity ratio is -1.28, with the most recent change of +0.08 (+5.88%) on June 30, 2023. Over the past year, it has increased by +0.44 (+25.58%).PRTK Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.6% | +25.6% |
| 3 y3 years | +77.2% | +68.9% |
| 5 y5 years | -308.3% | -150.0% |
PRTK Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -131.2% | -109.0% |
Paratek Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -1.28(-5.9%) |
| Mar 2023 | - | -1.36(-9.3%) |
| Dec 2022 | -1.50(-24.6%) | -1.50(-3.8%) |
| Sept 2022 | - | -1.56(-9.3%) |
| June 2022 | - | -1.72(-5.5%) |
| Mar 2022 | - | -1.82(-8.5%) |
| Dec 2021 | -1.99(-18.8%) | -1.99(-17.4%) |
| Sept 2021 | - | -2.41(-5.5%) |
| June 2021 | - | -2.55(+20.9%) |
| Mar 2021 | - | -2.11(-13.9%) |
| Dec 2020 | -2.45(-62.8%) | -2.45(-22.0%) |
| Sept 2020 | - | -3.14(-23.8%) |
| June 2020 | - | -4.12(-12.9%) |
| Mar 2020 | - | -4.73(-28.1%) |
| Dec 2019 | -6.58(-236.8%) | -6.58(+2.7%) |
| Sept 2019 | - | -6.41(-66.3%) |
| June 2019 | - | -19.02(-233.0%) |
| Mar 2019 | - | 14.30(+197.3%) |
| Dec 2018 | 4.81(+568.1%) | 4.81(+21.2%) |
| Sept 2018 | - | 3.97(+55.1%) |
| June 2018 | - | 2.56(+374.1%) |
| Mar 2018 | - | 0.54(-25.0%) |
| Dec 2017 | 0.72(+33.3%) | 0.72(+46.9%) |
| Sept 2017 | - | 0.49(+14.0%) |
| June 2017 | - | 0.43(-6.5%) |
| Mar 2017 | - | 0.46(-14.8%) |
| Dec 2016 | 0.54(+184.2%) | 0.54(+134.8%) |
| Sept 2016 | - | 0.23(+27.8%) |
| June 2016 | - | 0.18(-33.3%) |
| Mar 2016 | - | 0.27(+42.1%) |
| Dec 2015 | 0.19(>+9900.0%) | 0.19(+18.8%) |
| Sept 2015 | - | 0.16(>+9900.0%) |
| June 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00 | 0.00(0.0%) |
| Sept 2014 | - | 0.00(0.0%) |
| June 2014 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2013 | - | 0.00(0.0%) |
| June 2013 | - | 0.00(0.0%) |
| Mar 2013 | - | 0.00(0.0%) |
| Dec 2012 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2012 | - | 0.00(0.0%) |
| June 2012 | - | 0.00(0.0%) |
| Mar 2012 | - | 0.00(0.0%) |
| Dec 2011 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2011 | - | 0.00(0.0%) |
| June 2011 | - | 0.00(0.0%) |
| Mar 2011 | - | 0.00(0.0%) |
| Dec 2010 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2010 | - | 0.00(0.0%) |
| June 2010 | - | 0.00(0.0%) |
| Mar 2010 | - | 0.00(0.0%) |
| Dec 2009 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2009 | - | 0.00(0.0%) |
| June 2009 | - | 0.00(0.0%) |
| Mar 2009 | - | 0.00(-100.0%) |
| Dec 2008 | -0.06(<-9900.0%) | -0.06(<-9900.0%) |
| Sept 2008 | - | 0.00(0.0%) |
| June 2008 | - | 0.00(0.0%) |
| Mar 2008 | - | 0.00(0.0%) |
| Dec 2007 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2007 | - | 0.00(0.0%) |
| June 2007 | - | 0.00(0.0%) |
| Mar 2007 | - | 0.00(0.0%) |
| Dec 2006 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2006 | - | 0.00(0.0%) |
| June 2006 | - | 0.00(0.0%) |
| Mar 2006 | - | 0.00(0.0%) |
| Dec 2005 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2004 | 0.00(0.0%) | 0.00 |
| Dec 2002 | 0.00(0.0%) | - |
| Dec 2001 | 0.00 | - |
FAQ
- What is Paratek Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual debt to equity year-on-year change?
- What is Paratek Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly debt to equity year-on-year change?
What is Paratek Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of PRTK is -1.50
What is the all time high annual debt to equity for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual debt to equity ratio is 4.81
What is Paratek Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, PRTK annual debt to equity ratio has changed by +0.49 (+24.62%)
What is Paratek Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of PRTK is -1.28
What is the all time high quarterly debt to equity for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly debt to equity ratio is 14.30
What is Paratek Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, PRTK quarterly debt to equity ratio has changed by +0.44 (+25.58%)